Member Info for LTbeliever

IMO, we can discuss here endlessly amongst ourselves about the past, about the disappointments, delays etc which are understandable, especially for Shareholders who have been here for years; I have been one for just over a month so I cannot talk about the past; all I can say is:

1. Dan was very optimistic in the LSE interview, mid-October, expecting the FDA ODD "very soon"; obviously, then NFX was hit with the FDA query, which we can assume Dan had sat on for a few days, until the fund raise was out of the way; rightly or wrongly, he did what he thought was best for NFX and the Directors.

2. RNS issued straight after fundraise was over, telling us that "query was standard", data already existed, and that the Co would respond "ASAP";

3. We still don't know whether NFX responded and when, and how long after receipt of the fresh data the FDA can finalise its decision; shutdown may have created a backlog, we just don't know.

So we have 2 unknowns and IMO, the Co did respond to the FDA soon after the RNS was issued; not for us, but the RNS was issued probably to tell "partners" (if they exist) that everything was going ahead smoothly and it's now up to the FDA to issue the ODD designation. I think we can still hear about the ODD in the next 1-2 weeks, let's wait and see.

Looking at the past few years, before the AGM there's always been an RNS by eoNovember first, announcing the AGM date in December; but only once in the last few years there's been a material RNS released together with the AGM; so let's hope this year we do get a similar RNS about new business etc. GLA!

AFS were released by eoNovember, for the past 3 years, meaning that - if tradition holds - we are 1-5 days away from important news & numbers.

Https://www.nuformix.com/pipeline/

Has anyone noticed the changes/revamp of the website, done in just the past 8-9 days? Especially the pipeline section? It had not been updated for at least 2 years, so why spend precious cash to revamp NOW? Update was after the fund raising closed, so this shows that the revamp was NOT done for PIs considering taking part in the fund raise. Could it be in anticipation of "something bigger" happening soon? Clutching at straws maybe :)

Trombone, "How many of the posters on here will still be here IF a deal/partnership takes nfx into another 12 months of development with still no guarantee of success?"

Nobody knows; but you are assuming that the only investors in NFX are ST PIs, posting here; there are Investment funds that hold 100-200 small pharma cos, spreading execution risk; some may take an interest in NFX after an FDA ODD, others after a p/ship deal; so, new investors may more than compensate for PIs exiting; all IMO, who knows for sure?

Maybe, but the devil will be in the details; 1. agreement 2. upfront pmnt of X millions 3. staged payments during the 12 months (as per Dan's LSE interview)of a clinical study 4. licensing fees for a successful product; you only referred to item 2. of the list.

FDA ODD delay RNS dropped the SP by 30% 2 weeks ago? So, first upside there; and does anyone believe that the SP reflects any collaboration deal?

Just hit 0.32; IMO "speculation' is Bitcoin as there is no inherent value, yield or way to evaluate (other than scammers hiding their ransom money and the mafia laundering funds using crypto).

On the other hand, NFX is high risk, yes, but we have EMA ODD since April, a lot of time and money spent on NPX002's research, FDA ODD designation "soon" as per recent RNS (only exact timing is speculation) and a high probability that such a designation will go hand in hand with a partner/collaboration/licensing agreement.

Appx 200k has been spent buying shares in big chunks during the preceding 2-3 days; IMO, these are not random buyers; they bought because they know something. We will know it too, soon enough.

Speculators in overvalued, hyped fads (AI, Bitcoin etc) are getting slaughtered; is NFX overvalued at this level or not? This is the question people need to ask themselves.

2 delayed trades for 30 mln shares from yesterday; very committed :)

Another 20.000 appx of trades - delayed from the morning.

Another coincidence :) a 20.000 trade this morning.

The announced volumes (low) seem to indicate that there are big orders pending for execution - which we'd probably see around close today, or even tomorrow; and IMO, these should be for LT holders taking a position for 2026.

If the SA economy picks up, energy supply/prices stabilise etc, there will be fewer production problems and more domestic demand for IRON's production of metals.

Part II:

Despite the progress, Godongwana argues that he’s only beginning. Speaking at the inaugural Bloomberg Africa Business Summit in Johannesburg this week, he promised to adopt a new fiscal anchor. This won’t be straightforward. The ruling coalition is fragile, and this is likely to face political opposition.

Still, he’s determined to push through the reform to stabilize the debt-to-GDP ratio this fiscal year. That will hinge on a spending restraint that’s likely to upset voters. But inflation, which accelerated less than expected, remains within the central bank’s comfort zone, possibly mitigating the painful effects of fiscal consolidation. Consumer prices rose 3.6% in October, compared with 3.4% a month earlier. Bloomberg Economics’ Yvonne Mhango sees inflation climbing to 3.9% by year-end, although she expects a stronger rand and faster-than-expected fiscal tightening to help contain the rise. It remains in South Africa’s interest to keep Washington at arm’s length.

Nice write up on Bberg, especially re market sentiment improving and reduction in corruption and energy cuts:

"In May, South African President Cyril Ramaphosa arrived at the White House hoping to dislodge Trump’s allegations of a so-called “white genocide” that the administration used to levy punitive tariffs on imports from the country. Ramaphosa received a dressing-down and left Washington empty-handed. The meeting worsened already frayed ties, culminating in Trump’s boycott of this week’s G-20 summit in Johannesburg. The 30% tariff remains in place, threatening to derail the economy just as painstaking reforms were beginning to take hold. And yet South African assets are thriving in ways few in Washington or Pretoria anticipated. Last week, Finance Minister Enoch Godongwana delivered an impressive budget update in which revenue exceeded previous projections, prompting the National Treasury to double down on its fiscal-consolidation plans. Inflation’s trajectory has turned, enabling the central bank to target 3% inflation rather than a 3% to 6% band. Another vote of confidence came from S&P Global Ratings, which upgraded South Africa’s credit assessment for the first time since 2005 and kept a positive outlook. Few would have predicted such an endorsement in the immediate aftermath of Washington’s tariff shock. The weak dollar has helped. The rand gained almost 10% this year, while South African 10-year credit default swaps are at their lowest since 2014 as the cost of financing dollar-denominated debt eases. Equities have widened their lead against emerging market peers.

With the US row still casting a long shadow, the market activity suggests a deeper confidence in reform momentum. A serious breakdown in relations with Washington isn’t trivial. Trade and investment ties remain vital. But the gains from Pretoria’s policy overhaul are hard to ignore. This is most evident in the near-elimination of the crippling power shortages that had been a defining symbol of economic malaise. For now, as yields on the country’s benchmark bonds plunge, bullish sentiments are their highest in two decades.

These green shoots are encouraging for an economy long hobbled by entrenched corruption and brazen, violent crime. The reforms are encouraging private investment in ailing state-owned enterprises in energy and logistics. Land reforms that draw the ire of Elon Musk, a former Trump ally, are also ongoing. And there was the vintage selloff ahead of last year’s elections which created great a chance to buy. The surprising stability since the vote also helped to expand the multiples that investors are prepared to pay for South African stocks. It long commanded a premium to the rest of the emerging world, which was wiped out under former President Jacob Zuma. Valuations have resurged of late, and almost brought the country back in line with other emergents...

Somebody scooping up large chunks - coincidence?

Interesting last 2 trades, from this morning.

Somebody (or more than one?) bought, in big, delayed chunks, almost 140.000 worth of shares in the past 24 hours; IMO, that's a sign that the designation is not far off. Of course, maybe they are just crazy, who knows?

Dan said - 1 month ago - that he expected the designation "imminently"; then the query came, almost 2 weeks ago and an RNS was released to assure the Market that the query was being addressed ASAP.